SEP 27, 2017 09:00 AM PDT

WEBINAR: Challenges in CMV Management

Speakers
  • Medical Director, Molecular Infectious Diseases, ARUP Laboratories
    Biography
      Dr. Hillyard is a professor of pathology at the University of Utah School of Medicine. Dr. Hillyard received his MD from the Columbia University College of Physicians and Surgeons. His training was in anatomic and clinical pathology, with fellowships in medical microbiology and microbial genetics.

    Abstract:

    DATE:  September 27, 2017

    TIME:   9:00am PT, 12:00pm ET

    Transplant Educational Webinar Series

    Challenges in CMV Management 

    Management of CMV infected and immunocompromised individuals at risk for life-threatening post-transplantation complications is critically dependent on accurate viral load testing.  While the widespread adoption of international CMV standards for test calibration has improved test comparability, significant inter-assay variation among CMV tests remains.

    Please join Dr. David Hillyard, Medical Director for Molecular Infectious Testing at ARUP Laboratories, in this second part of our webinar series for a discussion of recent advances in CMV test standardization and its implications for management of CMV infected patients.

    Learning objectives:
    1)    Overview of NAT in management of CMV
    2)    The value of CMV test standardization
    3)    Recent insights into the challenge of CMV standardization and implications for other viral load tests


    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    MAY 24, 2018 09:00 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:00 AM PDT
    Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
    MAY 29, 2018 09:00 AM PDT
    C.E. CREDITS
    MAY 29, 2018 09:00 AM PDT
    Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
    Loading Comments...